Vesalius Cardiovascular Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $7.24M

  • Investors
  • 3

Vesalius Cardiovascular General Information

Description

Developer of a transfemoral mitral valve repair device designed for degenerative mitral regurgitation of heart valve disease. The company's device is based on current surgical techniques of chordal replacement and annuloplasty, and it can treat any diseased area of the valve and covers the full range of valve sizes, enabling physicians to get a device that is adaptable and deployment-reversible.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 200 - 210 West Broadway
  • Suite 200
  • Vancouver, British Columbia V5Y 3W2
  • Canada
+1 (604)
Primary Industry
Surgical Devices
Vertical(s)
Corporate Office
  • 200 - 210 West Broadway
  • Suite 200
  • Vancouver, British Columbia V5Y 3W2
  • Canada
+1 (604)

Vesalius Cardiovascular Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vesalius Cardiovascular Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 29-Aug-2025 $7.24M Completed Pre-Clinical Trials
7. Later Stage VC 22-Aug-2025 Completed Pre-Clinical Trials
6. Later Stage VC (Series A) 24-Jan-2022 Completed Pre-Clinical Trials
5. Seed Round 30-Sep-2020 Completed Pre-Clinical Trials
4. Accelerator/Incubator 10-Sep-2020 Completed Product Development
3. Grant 09-May-2019 Completed Product Development
2. Seed Round 10-Apr-2018 $2.48M $2.48M Completed Product Development
1. Accelerator/Incubator 01-Nov-2016 Completed Product Development
To view Vesalius Cardiovascular’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Vesalius Cardiovascular Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a transfemoral mitral valve repair device designed for degenerative mitral regurgitation of heart valve dis
Surgical Devices
Vancouver, Canada
12 As of 2026

Radolfzell, Germany
 

Trondheim, Norway
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vesalius Cardiovascular Competitors (3)

One of Vesalius Cardiovascular’s 3 competitors is CoreMedic, a Venture Capital-Backed company based in Radolfzell, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CoreMedic Venture Capital-Backed Radolfzell, Germany
CardioMech Venture Capital-Backed Trondheim, Norway
NeoChord Venture Capital-Backed Maple Grove, MN
You’re viewing 3 of 3 competitors. Get the full list »

Vesalius Cardiovascular Patents

Vesalius Cardiovascular Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4656161-A1 Heart valve repair apparatus Pending 29-May-2024
US-12514705-B2 Heart valve repair apparatus Active 29-May-2024
US-20250366988-A1 Heart valve repair apparatus Active 29-May-2024
US-20260069417-A1 Heart valve repair apparatus Pending 29-May-2024
US-12702543-B2 Tissue anchors Active 29-May-2024 A61F2/24
To view Vesalius Cardiovascular’s complete patent history, request access »

Vesalius Cardiovascular Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vesalius Cardiovascular Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Canadian Technology Accelerator Accelerator/Incubator
VGH and UBC Hospital Foundation Corporation
HATCH Venture Builder Accelerator/Incubator Minority
To view Vesalius Cardiovascular’s complete investors history, request access »

Vesalius Cardiovascular FAQs

  • When was Vesalius Cardiovascular founded?

    Vesalius Cardiovascular was founded in 2016.

  • Where is Vesalius Cardiovascular headquartered?

    Vesalius Cardiovascular is headquartered in Vancouver, Canada.

  • What is the size of Vesalius Cardiovascular?

    Vesalius Cardiovascular has 12 total employees.

  • What industry is Vesalius Cardiovascular in?

    Vesalius Cardiovascular’s primary industry is Surgical Devices.

  • Is Vesalius Cardiovascular a private or public company?

    Vesalius Cardiovascular is a Private company.

  • What is Vesalius Cardiovascular’s current revenue?

    The current revenue for Vesalius Cardiovascular is .

  • How much funding has Vesalius Cardiovascular raised over time?

    Vesalius Cardiovascular has raised $23.3M.

  • Who are Vesalius Cardiovascular’s investors?

    Canadian Technology Accelerator, VGH and UBC Hospital Foundation, and HATCH Venture Builder have invested in Vesalius Cardiovascular.

  • Who are Vesalius Cardiovascular’s competitors?

    CoreMedic, CardioMech, and NeoChord are competitors of Vesalius Cardiovascular.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process